#1102 Global Rank Marché Ouvert

Gilles Martin

Santé & Biotech. Laboratory services.

Fortune Nette (Est.)

$3.9 B
-$27 (-0.00%) Aujourd'hui
Portefeuille : Eurofins Scientific Societe Europeenne ▼ Volatile
Gilles Martin

Photo: Press Agency / 2026

Profil Financier

Gilles Martin occupe actuellement le rang #1102 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $3.9 B (-$27 sur 24h).

Gilles Martin is the executive chairman of Eurofins Scientific, a Luxembourg-based laboratory services company listed on the French stock exchange.

Martin, who founded the original lab in 1987, owns an estimated 22% of the company through the family's holding company Analytical Bioventures.

His brother Yves-Loic owns an estimated 10% stake. He served as CTO from 1998 until 2015 and now is a board member.

Eurofins has 900 labs in 61 countries and is prominent in food and pharmaceutical products testing.

Historique de Fortune (12 Mois)

1A 5A Max
Jan 25 Juin 25 Déc 25 Auj.

Répartition des Actifs

Actif / Société Parts Détenues Valeur Est. Tendance
Eurofins Scientific Societe Europeenne (ERF-FR) 43.0M parts $3.6 B Volatile